Related Experiment Video
Updated: May 1, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma
Mark N Jabbour1, Muhieddine Seoud, Hikmat Al-Ahmadie
1Departments of Pathology and Laboratory Medicine (M.N.J., G.S.Z.) Obstetrics and Gynecology (M.S.), American University of Beirut Medical Center, Beirut, Lebanon Department of Pathology (H.AL-A), Memorial Sloan-Kettering Cancer Center, New York, New York Department of Anatomic Pathology (F.W.A-K), Cleveland Clinic, Cleveland, Ohio.
Abstract:
Alveolar soft part sarcoma of the vulvovaginal region is limited to only 8 reported vaginal cases and 1 vulvar case in the English literature. The histogenesis of the tumor remains intriguing with postulates favoring a myogenic versus nonmyogenic origin. A reciprocal translocation for ASPL-TFE3 gene fusion, frequently detected in ~90% of cases, combined with TFE3 protein immunoexpression are highly sensitive and specific methods for diagnostic confirmation. The current report describes a unique case of vulvovaginal alveolar soft part sarcoma showing the classic morphologic features with documentation of TFE3 protein expression and the ASPL-TFE3 gene rearrangement. Furthermore, a brief review of the literature of vulvar and vaginal alveolar soft part sarcoma cases with the various treatment modalities is outlined.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer

